Clinical trial
Using Gene Modified Neuroblastoma Cells for the Treatment of Relapsed/Refractory…
NCT00062855 · Baylor College of Medicine, Other · Completed
Key facts
| NCT number | NCT00062855 |
|---|---|
| Title | Using Gene Modified Neuroblastoma Cells for the Treatment of Relapsed/Refractory Neuroblastoma |
| Official title | Phase I Study of Chemokine and Cytokine Gene Modified Autologous Neuroblastoma Cells for Treatment of Relapsed/Refractory Neuroblastoma Using an Adenoviral Vector (CYCHE) |
| Acronym | CYCHE |
| Lead sponsor | Baylor College of Medicine, Other |
| Collaborators | Center for Cell and Gene Therapy, Baylor College of Medicine |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Neuroblastoma |
| Intervention type | Genetic, Procedure |
| Interventions | Skin Biopsy, Gene Modified Neuroblastoma Cells |
| Enrollment | 9 |
| Start date | Nov 1, 1997 |
| Primary completion | Aug 1, 2001 |
| Completion | Mar 1, 2006 |
| First posted | Jun 18, 2003 |
| Last update posted | Oct 29, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: